Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 167.30 EUR | +2.01% |
|
-9.91% | -20.33% |
| 07-24 | SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating | ZD |
| 07-24 | Sartorius Stedim Biotech S.A., H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 16.28B 18.53B 15.14B 13.89B 26.1B 1,785B 26.5B 180B 70.23B 877B 69.57B 68.07B 3,034B | P/E 2026 * |
43.7x | P/E 2027 * | 33.1x |
|---|---|---|---|---|---|
| Enterprise Value | 18.29B 20.82B 17.01B 15.61B 29.32B 2,005B 29.78B 202B 78.9B 986B 78.16B 76.48B 3,408B | EV / Sales 2026 * |
5.84x | EV / Sales 2027 * | 5.19x |
| Free-Float |
28.47% | Yield 2026 * |
0.49% | Yield 2027 * | 0.61% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +2.01% | ||
| 1 week | -9.91% | ||
| Current month | -7.87% | ||
| 1 month | -1.12% | ||
| 3 months | +3.08% | ||
| 6 months | -18.79% | ||
| Current year | -20.33% |
| 1 week | 158.9 |  | 187.4 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 287.8 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.01% | -9.91% | -4.54% | -38.70% | 18.53B | |
| +2.29% | +2.36% | -17.97% | -10.09% | 180B | |
| +1.46% | +0.01% | -9.87% | -6.25% | 107B | |
| +1.58% | +0.65% | +6.69% | +61.86% | 60.29B | |
| -1.13% | -2.60% | +26.37% | +54.76% | 50.19B | |
| +2.22% | -1.14% | -14.85% | -44.15% | 43.08B | |
| +2.98% | -2.61% | - | - | 32.77B | |
| +1.50% | -6.67% | -17.52% | -43.99% | 27.61B | |
| -7.67% | -8.39% | +17.59% | -12.73% | 23.1B | |
| +1.63% | -1.73% | -5.80% | -7.80% | 20.86B | |
| Average | +0.69% | -3.00% | -2.21% | -5.23% | 56.25B | |
| Weighted average by Cap. | +1.30% | -0.71% | -6.56% | -0.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.56B 2.91B 2.67B 5.02B 343B 5.1B 34.56B 13.5B 169B 13.38B 13.09B 583B | 3.48B 3.96B 3.23B 2.97B 5.58B 381B 5.66B 38.41B 15.01B 188B 14.87B 14.55B 648B |
| Net income | 370M 421M 344M 316M 593M 40.58B 603M 4.09B 1.6B 19.95B 1.58B 1.55B 68.97B | 481M 548M 448M 411M 772M 52.79B 784M 5.32B 2.08B 25.95B 2.06B 2.01B 89.73B |
| Net Debt | 2.01B 2.29B 1.87B 1.72B 3.22B 220B 3.27B 22.2B 8.67B 108B 8.59B 8.41B 375B | 1.77B 2.01B 1.64B 1.51B 2.83B 194B 2.88B 19.52B 7.62B 95.26B 7.55B 7.39B 329B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | €167.30 | +2.01% | 105,317 |
| 26-07-23 | €164.00 | -6.45% | 215,014 |
| 26-07-22 | €175.30 | +5.22% | 134,439 |
| 26-07-21 | €166.60 | -7.55% | 213,161 |
| 26-07-20 | €180.20 | -2.96% | 55,079 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
